VRTX has over 1,800 employees. I estimate out of those there are 1000 scientists. Yet we have no other drugs even in phase 1 as far as I can see. Jeff Leiden has chosen this path -- putting all of the eggs in CF basket. If the results are not very good the PPs may go down to maybe $35. If that happens he and his team should resign and the Board should put the company's skeleton on the auction block maybe to get $40 a share if we are lucky.
I have a substantial number of shares in this company and plan to stick with it for the hopefully good results. But if good result are not produced I believe this management has to pay with their jobs. If the results are good this management should be highly rewarded by the board.
let's think positive dude -- a little too close to the results to be so negative. it you think it is going to 35 why don't you sell here and save yourself 30 bucks. I am in it because there is a high probability of success given the phase ii results. in bio there is no gaurantees don't listen the short driven sa mf and street driven articles.
"it you think it is going to 35 why don't you sell here and save yourself 30 bucks."
Dude, I did not say it will.
I said IF it does, then the management should be fired. You do not need to preach to me that biotechs are risky. I know that. However, that does not mean that managements can keep drawing high salaries and lots of options without accountability to their shareholders who are paying them all of these benefits!